Page last updated: 2024-10-31

mitotane and Adenoma, Adrenal Cortical

mitotane has been researched along with Adenoma, Adrenal Cortical in 1 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demeure, MJ1
Stephan, E1
Sinari, S1
Mount, D1
Gately, S1
Gonzales, P1
Hostetter, G1
Komorowski, R1
Kiefer, J1
Grant, CS1
Han, H1
Von Hoff, DD1
Bussey, KJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Multicenter, Prospective, Non-randomized, Phase II Trial Designed to Evaluate the Activity of Cabazitaxel in Patients With Advanced Adreno-Cortical- Carcinoma Progressing After Previous Chemotherapy Lines[NCT03257891]Phase 225 participants (Anticipated)Interventional2018-01-25Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for mitotane and Adenoma, Adrenal Cortical

ArticleYear
Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer.
    Annals of surgery, 2012, Volume: 255, Issue:1

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Albumin-Bound Paclitaxel; Albumins; Animals; Antin

2012